These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11527547)

  • 1. The cannabinoid CB(1) receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamus.
    Tzavara ET; Perry KW; Rodriguez DE; Bymaster FP; Nomikos GG
    Eur J Pharmacol; 2001 Aug; 426(3):R3-4. PubMed ID: 11527547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxyl ic acid phenylamide (CP-272871) for the CB(1) cannabinoid receptor.
    Meschler JP; Kraichely DM; Wilken GH; Howlett AC
    Biochem Pharmacol; 2000 Nov; 60(9):1315-23. PubMed ID: 11008125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptors.
    Hough LB; Nalwalk JW; Stadel R; Timmerman H; Leurs R; Paria BC; Wang X; Dey SK
    J Pharmacol Exp Ther; 2002 Oct; 303(1):314-22. PubMed ID: 12235266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the cannabinoid CB(1) receptor antagonist, SR141716A, after Delta(9)-tetrahydrocannabinol withdrawal.
    Beardsley PM; Martin BR
    Eur J Pharmacol; 2000 Jan; 387(1):47-53. PubMed ID: 10633159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions.
    Tzavara ET; Davis RJ; Perry KW; Li X; Salhoff C; Bymaster FP; Witkin JM; Nomikos GG
    Br J Pharmacol; 2003 Feb; 138(4):544-53. PubMed ID: 12598408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid receptor antagonism and inverse agonism in response to SR141716A on cAMP production in human and rat brain.
    Mato S; Pazos A; Valdizán EM
    Eur J Pharmacol; 2002 May; 443(1-3):43-6. PubMed ID: 12044790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A) interaction with LYS 3.28(192) is crucial for its inverse agonism at the cannabinoid CB1 receptor.
    Hurst DP; Lynch DL; Barnett-Norris J; Hyatt SM; Seltzman HH; Zhong M; Song ZH; Nie J; Lewis D; Reggio PH
    Mol Pharmacol; 2002 Dec; 62(6):1274-87. PubMed ID: 12435794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CB(1) receptor antagonist SR141716A inhibits Ca(2+)-induced relaxation in CB(1) receptor-deficient mice.
    Bukoski RD; Bátkai S; Járai Z; Wang Y; Offertaler L; Jackson WF; Kunos G
    Hypertension; 2002 Feb; 39(2):251-7. PubMed ID: 11847193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
    Craft RM; Wakley AA; Tsutsui KT; Laggart JD
    J Pharmacol Exp Ther; 2012 Mar; 340(3):787-800. PubMed ID: 22182934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A.
    Aceto MD; Scates SM; Lowe JA; Martin BR
    Eur J Pharmacol; 1995 Aug; 282(1-3):R1-2. PubMed ID: 7498260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid receptor antagonist reduces heroin self-administration only in dependent rats.
    Navarro M; Carrera MR; Del Arco I; Trigo JM; Koob GF; Rodríguez de Fonseca F
    Eur J Pharmacol; 2004 Oct; 501(1-3):235-7. PubMed ID: 15464083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat.
    Beaulieu1 P; Bisogno1 T; Punwar S; Farquhar-Smith WP; Ambrosino G; Di Marzo V; Rice AS
    Eur J Pharmacol; 2000 May; 396(2-3):85-92. PubMed ID: 10822060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus effects of BAY 38-7271, a novel cannabinoid receptor agonist.
    De Vry J; Rüdiger Jentzsch K
    Eur J Pharmacol; 2002 Dec; 457(2-3):147-52. PubMed ID: 12464360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cannabinoid receptor antagonist SR 141716 prevents acquisition of drinking behavior in alcohol-preferring rats.
    Serra S; Carai MA; Brunetti G; Gomez R; Melis S; Vacca G; Colombo G; Gessa GL
    Eur J Pharmacol; 2001 Nov; 430(2-3):369-71. PubMed ID: 11711056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral mechanisms underlying inhibition of food-maintained responding by the cannabinoid receptor antagonist/inverse agonist SR141716A.
    De Vry J; Schreiber R; Eckel G; Jentzsch KR
    Eur J Pharmacol; 2004 Jan; 483(1):55-63. PubMed ID: 14709326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells.
    Bensaid M; Gary-Bobo M; Esclangon A; Maffrand JP; Le Fur G; Oury-Donat F; Soubrié P
    Mol Pharmacol; 2003 Apr; 63(4):908-14. PubMed ID: 12644592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticotropin-releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis.
    Lavicky J; Dunn AJ
    J Neurochem; 1993 Feb; 60(2):602-12. PubMed ID: 7678287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid CB(1) receptor blockade enhances the protective effect of melanocortins in hemorrhagic shock in the rat.
    Cainazzo MM; Ferrazza G; Mioni C; Bazzani C; Bertolini A; Guarini S
    Eur J Pharmacol; 2002 Apr; 441(1-2):91-7. PubMed ID: 12007925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade by the cannabinoid CB(1) receptor antagonist, SR 141716, of alcohol deprivation effect in alcohol-preferring rats.
    Serra S; Brunetti G; Pani M; Vacca G; Carai MA; Gessa GL; Colombo G
    Eur J Pharmacol; 2002 May; 443(1-3):95-7. PubMed ID: 12044797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure-activity relationships of amide and hydrazide analogues of the cannabinoid CB(1) receptor antagonist N-(piperidinyl)- 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716).
    Francisco ME; Seltzman HH; Gilliam AF; Mitchell RA; Rider SL; Pertwee RG; Stevenson LA; Thomas BF
    J Med Chem; 2002 Jun; 45(13):2708-19. PubMed ID: 12061874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.